Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 51Unknown 21Recruiting 11Terminated 10Withdrawn 5Not yet recruiting 4Suspended 3Enrolling by invitation 2Active not recruiting 2

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 438Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 176Colorectal Neoplasms 158Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 131Lymphoma 128Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Head and Neck Neoplasms 101Brain Neoplasms 101Recurrence 100Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 75Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Interventions

Certolizumab Pegol 2Ustekinumab 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × Crohn Disease × Clear all
NCT04971525 2025-07-08

A Study to Check How Often People Treated With Darvadstrocel for Crohn's Disease Are Diagnosed With Cancer

Takeda

Withdrawn

Crohn Disease

NCT04655807 2025-04-27

DUET

Janssen Research & Development, LLC

Phase 2 Withdrawn

Crohn Disease

NCT05246943 2023-04-25

The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients

The University of Texas Medical Branch, Galveston

Withdrawn
Gastrointestinal

Diverticular Diseases, Colitis, Ulcerative, Crohn Disease, Thrombosis, Colorectal Neoplasms, Venous Thrombosis

NCT00354367 2012-05-28

Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas

UCB Pharma

Phase 3 Withdrawn

Crohn Disease, Fistula

NCT00358683 2012-05-28

A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease

UCB Pharma

Phase 3 Withdrawn

Crohn Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡